174 related articles for article (PubMed ID: 32508750)
41. Functional assessment of the thyrotropin receptor-beta subunit.
Ciullo I; Latif R; Graves P; Davies TF
Endocrinology; 2003 Jul; 144(7):3176-81. PubMed ID: 12810574
[TBL] [Abstract][Full Text] [Related]
42. Expression of beta-arrestins in toxic and cold thyroid nodules.
Voigt C; Holzapfel H; Paschke R
FEBS Lett; 2000 Dec; 486(3):208-12. PubMed ID: 11119705
[TBL] [Abstract][Full Text] [Related]
43. Biased signaling by thyroid-stimulating hormone receptor-specific antibodies determines thyrocyte survival in autoimmunity.
Morshed SA; Ma R; Latif R; Davies TF
Sci Signal; 2018 Jan; 11(514):. PubMed ID: 29363585
[TBL] [Abstract][Full Text] [Related]
44. Is There Evidence for IGF1R-Stimulating Abs in Graves' Orbitopathy Pathogenesis?
Krieger CC; Neumann S; Gershengorn MC
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911689
[TBL] [Abstract][Full Text] [Related]
45. Functional thyrotropin receptor expression in the pituitary folliculo-stellate cell line TtT/GF.
Brokken LJ; Bakker O; Wiersinga WM; Prummel MF
Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):13-20. PubMed ID: 15662590
[TBL] [Abstract][Full Text] [Related]
46. Genetic confirmation for a central role for TNFα in the direct action of thyroid stimulating hormone on the skeleton.
Sun L; Zhu LL; Lu P; Yuen T; Li J; Ma R; Baliram R; Moonga SS; Liu P; Zallone A; New MI; Davies TF; Zaidi M
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9891-6. PubMed ID: 23716650
[TBL] [Abstract][Full Text] [Related]
47. TSH-induced gene expression involves regulation of self-renewal and differentiation-related genes in human bone marrow-derived mesenchymal stem cells.
Bagriacik EU; Yaman M; Haznedar R; Sucak G; Delibasi T
J Endocrinol; 2012 Feb; 212(2):169-78. PubMed ID: 22128326
[TBL] [Abstract][Full Text] [Related]
48. TSH induces metallothionein 1 in thyrocytes via Gq/11- and PKC-dependent signaling.
Bäck CM; Stohr S; Schäfer EA; Biebermann H; Boekhoff I; Breit A; Gudermann T; Büch TR
J Mol Endocrinol; 2013; 51(1):79-90. PubMed ID: 23613280
[TBL] [Abstract][Full Text] [Related]
49. Thyroid stimulating hormone stimulates the expression of glucose transporter 2 via its receptor in pancreatic β cell line, INS-1 cells.
Lyu J; Imachi H; Yoshimoto T; Fukunaga K; Sato S; Ibata T; Kobayashi T; Dong T; Yonezaki K; Yamaji N; Kikuchi F; Iwama H; Ishikawa R; Haba R; Sugiyama Y; Zhang H; Murao K
Sci Rep; 2018 Jan; 8(1):1986. PubMed ID: 29386586
[TBL] [Abstract][Full Text] [Related]
50. Regulation of thyrotropin receptor gene expression in 3T3-L1 adipose cells is distinct from its regulation in FRTL-5 thyroid cells.
Shimura H; Haraguchi K; Endo T; Onaya T
Endocrinology; 1997 Apr; 138(4):1483-90. PubMed ID: 9075706
[TBL] [Abstract][Full Text] [Related]
51. Thyrotropin (TSH)-induced receptor internalization in nonthyroidal cells transfected with a human TSH-receptor complementary deoxyribonucleic acid.
Heldin NE; Gustavsson B; Hermansson A; Westermark B
Endocrinology; 1994 May; 134(5):2032-6. PubMed ID: 8156904
[TBL] [Abstract][Full Text] [Related]
52. Effect of solubilization of porcine thyrotropin (TSH) receptor on TSH binding and on radio-receptor assay for anti-TSH receptor antibodies.
Watanabe Y; Tada H; Hidaka Y; Takano T; Amino N
Biochem Biophys Res Commun; 1998 Jul; 248(1):110-4. PubMed ID: 9675095
[TBL] [Abstract][Full Text] [Related]
53. Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2011 Feb; 21(2):169-76. PubMed ID: 20954819
[TBL] [Abstract][Full Text] [Related]
54. Thyrotropin receptor antibodies: new insights into their actions and clinical relevance.
Ando T; Latif R; Davies TF
Best Pract Res Clin Endocrinol Metab; 2005 Mar; 19(1):33-52. PubMed ID: 15826921
[TBL] [Abstract][Full Text] [Related]
55. Thyrotropin, Hyperthyroidism, and Bone Mass.
Kim SM; Ryu V; Miyashita S; Korkmaz F; Lizneva D; Gera S; Latif R; Davies TF; Iqbal J; Yuen T; Zaidi M
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4809-e4821. PubMed ID: 34318885
[TBL] [Abstract][Full Text] [Related]
56. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
Kosugi S; Ban T; Kohn LD
Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
[TBL] [Abstract][Full Text] [Related]
57. The Pathogenic TSH β-subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR.
Kalveram L; Kleinau G; Szymańska K; Scheerer P; Rivero-Müller A; Grüters-Kieslich A; Biebermann H
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703413
[TBL] [Abstract][Full Text] [Related]
58. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
59. Role of asparagine-linked oligosaccharides in protein folding, membrane targeting, and thyrotropin and autoantibody binding of the human thyrotropin receptor.
Nagayama Y; Namba H; Yokoyama N; Yamashita S; Niwa M
J Biol Chem; 1998 Dec; 273(50):33423-8. PubMed ID: 9837919
[TBL] [Abstract][Full Text] [Related]
60. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.
Grasberger H; Van Sande J; Hag-Dahood Mahameed A; Tenenbaum-Rakover Y; Refetoff S
J Clin Endocrinol Metab; 2007 Jul; 92(7):2816-20. PubMed ID: 17456567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
